Skip to main content

Table 5 Multivariate analysis for PFS and OS of 216 patients with multiple myeloma

From: Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience

Variable

PFS

OS

HR

95% CI

P value

HR

95% CI

P value

LDH > 250 U/L

1.494

1.020–2.189

0.039

2.791

1.692–4.604

< 0.001

ISS stage III

1.298

1.032–1.633

0.026

1.533

1.096–2.145

0.013

IgD subtype

2.221

1.221–4.040

0.009

3.506

1.687–7.285

0.001

1q21 amplification

–

–

–

1.949

1.179–3.224

0.009

IGH rearrangement

1.615

1.260–2.071

< 0.001

1.485

1.165–1.895

0.001

Extramedullary infiltration

2.084

1.421–3.055

< 0.001

3.692

2.199–6.200

< 0.001

  1. PFS progression-free survival, OS overall survival, HR hazard ratio, CI confidence interval, LDH lactate dehydrogenase, ISS international staging system, IgD immunoglobulin D, IGH immunoglobulin heavy chain gene
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us